Liquid Biopsies – News and Features

News
Affymetrix and ScreenCell Announce Worldwide Distribution Agreement
Affymetrix releases first circulating tumour cell platform technology for 4-color RNA-ISH.

News
Affymetrix and ScreenCell Announce Worldwide Distribution Agreement for CTC Technology
Combination of ScreenCell’s isolation devices and Affymetrix’ QuantiGene® ViewRNA ISH technology enables easy, accessible, sensitive, multiplex, low-cost system to enumerate and characterize CTCs and other rare cells.

News
Ariosa Diagnostics Announces Completion of Laboratory-Developed Test Study for Prenatal Test
Company to present additional Harmony(TM) Prenatal Test data at the 2012 American College of Medical Genetics Annual Clinical Genetics Meeting.

News
Comparison of Microfluidic Digital PCR and Conventional Quantitative PCR for Measuring Copy Number Variation
This study uses an in vitro BC gene amplification model to identify when a CNV is too small to be measured by qPCR and dPCR. Subsequently, we developed a model, based on the Poisson and binomial distributions, to determine the variance inherent in dPCR.

News
National Cancer Institute Awards Two Lung Cancer CTC Development Contracts to Cynvenio Biosystems, Inc.
Company also announces additional equity investment of $2.0 million.

News
Aria Announces Publication of Independent Study in the American Journal of Obstetrics & Gynecology Using Aria's Technology
Study, which exclusively examines women in their first trimester of pregnancy, provides largest data set to date for trisomy 18 pregnancies.

News
RPS Appoints Mark D. Myslinski Chief Executive Officer
Myslinski brings nearly 30 years of successful leadership experience in life sciences and diagnostic companies ranging from Fortune 100 companies to small, venture-backed start up organizations.

News
Aria Diagnostics Announces Launch of U.S. Clinical Study Comparing New Non-Invasive Prenatal Test to Current Standard
Additional information on company plans and activities to be shared with investors at the 30th Annual JP Morgan Healthcare Conference.

News
Aria Diagnostics Secures $52.7 Million in Oversubscribed Series C Financing
Financing will support development and commercialization of new non-invasive prenatal test.

News
Risk-Free Non-Invasive Prenatal Paternity Test Announced
International DNA testing company easyDNA Limited launched the new, 100% risk-free prenatal paternity test to supercede current invasive methodologies.
Advertisement